Cha, Tai-Lung <br/><br/>
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.  [electronic resource] 

 -  Journal of the Formosan Medical Association = Taiwan yi zhi  Nov 2017 
 - 825-836 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0929-6646 
<br/><br/><label>Standard No.: </label>10.1016/j.jfma.2017.04.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Neoplasms--radiotherapy<br/>Clinical Trials as Topic<br/>Humans<br/>Male<br/>Prostatic Neoplasms, Castration-Resistant--pathology<br/>Radiopharmaceuticals--therapeutic use<br/>Radium--therapeutic use<br/>Treatment Outcome